ImmunologybioRxiv
A novel glucocorticoid and androgen receptor modulator reduces viral entry and innate immune inflammatory responses in the Syrian Hamster model of SARS-CoV-2
S. M. Rocha, A. C. Fagre, A. S. Latham…·R. B. Tjalkens
This paper shows that PT150, a glucocorticoid and androgen receptor antagonist, reduces SARS-CoV-2 replication and inflammatory responses in Syrian hamsters.
DOI 10.3389/fimmu.2022.811430